Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma

Annals of Surgical Oncology

Volumn 20, Issue 4, 2013, Pages 1114-1120

  Arrese, David ^a   McNally, Megan E ^b   Chokshi, Ravi ^c   Feria Arias, Enrique ^b   Schmidt, Carl ^b   Klemanski, Dori ^b   Gregory, Guy ^b   Khabiri, Hooman ^b   Shah, Manisha ^b   Bloomston, Mark ^b  

^a RIVERSIDE METHODIST HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BIOCHEMISTRY; BONE METASTASIS; BONE SCINTISCANNING; CANCER SURVIVAL; CARCINOID SYNDROME; CAUSE OF DEATH; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DEMOGRAPHY; DISEASE SEVERITY; EXTRAHEPATIC DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LIVER DISEASE; LIVER FAILURE; LIVER METASTASIS; LIVER TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; RETROPERITONEAL CANCER; RETROSPECTIVE STUDY; SYMPTOM; TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT RESPONSE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NEUROENDOCRINE; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84875224951     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2786-4     Document Type: Conference Paper

References (19)

1. T Berge F Linell 1976 Carcinoid tumors. Frequency in a defined population during a 12-year period Acta Pathol Microbiol Scand. 84 322 330 1:STN:280:DyaE283nsVGjsg%3D%3D
2. Pommier R. The role of surgery and chemoembolization in the management of carcinoid. Presented at California Carcinoid Fighters Conference, October 25, 2003.
3. Ramage JK, Davies AH, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005;54(Suppl 4): iv1-6.
4. P Ruszniewsi D Malka 2000 Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors Digestion. 62 Suppl 1 79 83 10.1159/000051860
5. J Banzo E Abos P Prats, et al. 2004 Carcinoid tumor and bone metastases: diagnosis by somatostatin receptor scintigraphy Rev Esp Med Nucl. 23 394 402 15625056 10.1157/13067825 1:STN:280:DC%2BD2cnkvVOqsw%3D%3D
6. M Bloomston M Shah EC Ellison, et al. 2007 Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned J Gastrointest Surg. 11 264 271 17458596 10.1007/s11605-007-0089-z
7. P Therasse SG Arbuck EA Eisenhaeur, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst. 92 205 216 10655437 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D
8. DC Desai TM O'Dorisio WJ Schirmer, et al. 2001 Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors Regul Pept. 96 113 117 11111016 10.1016/S0167-0115(00)00167-1 1:CAS:528:DC%2BD3cXosFeqtrY%3D
9. CG Moertel 1987 Karnofsky Memorial Lecture: an odyssey in the land of small tumors J Clin Oncol. 5 1503 1522
10. JK Ramage AH Davies 2003 Measurement of quality of life in carcinoid/neuroendocrine tumours Endocr Relat Cancer. 10 483 486 14713261 10.1677/erc.0.0100483 1:STN:280:DC%2BD2c%2Fhs1aksQ%3D%3D
11. JR Strosberg J Choi AB Cantor LK Kvols 2006 Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors Cancer Control. 13 72 78 16508629
12. S Gupta MM Johnson JC Yao 2005 Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variable affecting response rates and survival Cancer. 104 1590 1602 16134179 10.1002/cncr.21389
13. J Mansour H Chen 2004 Pancreatic endocrine tumors J Surg Res. 120 139 161 15172200 10.1016/j.jss.2003.12.007 1:CAS:528:DC%2BD2cXksVemsbo%3D
14. K Oberg 1996 The ultimate biochemical diagnosis of gastro-entero- pancreatic tumours Digestion. 57 Suppl 1 45 47 8813468
15. N Kimura A Funakoshi D Aunis K Tateishi W Miura H Nagura 1995 Immunohistochemical localization of chromostatin and pancreastatin, chromogranin A-derived bioactive peptides, in normal and neoplastic neuroendocrine tissues Endocr Pathol. 6 35 43 12114688 10.1007/BF02914987
16. van Persijn van Meerten EL, Gelderblum H, Bloem JL. RECIST revisited: implications for the radiologist. A review article on the modified RECIST guideline. Eur Radiol. 2010;20:1456-67.
17. S Gupta JC Yao JA Ajani, et al. 2003 Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the MD Anderson experience Cancer J. 9 261 267 12967136 10.1097/00130404- 200307000-00008
18. O Kress R Wagner M Wied KJ Klose R Arnold H Alfke 2003 Transarterial chemoembolization for advanced liver metastases of neuroendocrine tumors-a retrospective single-center analysis Digestion. 68 94 101 14593235 10.1159/000074522 1:CAS:528:DC%2BD2cXisF2jsQ%3D%3D
19. H Scherübl 2008 Tumor biology and prognosis of gastrointestinal carcinoids J Clin Oncol. 26 6012 6013 19018074 10.1200/JCO.2008.19.9711